دورية أكاديمية
أعرض في EDS

Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils.

التفاصيل البيبلوغرافية
العنوان: Evaluating the Skin Interactions and Permeation of Alginate/Fucoidan Hydrogels Per Se and Associated with Different Essential Oils.
المؤلفون: Barbosa AI; LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal., Lima SAC; LAQV, REQUIMTE, Departamento de Química, Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal., Yousef I; ALBA Synchrotron, Carrer de la Llum 2-26, Cerdanyola del Vallès, 08290 Barcelona, Spain., Reis S; LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
المصدر: Pharmaceutics [Pharmaceutics] 2023 Jan 05; Vol. 15 (1). Date of Electronic Publication: 2023 Jan 05.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Marine polysaccharides are recognized for their biological properties and their application in the drug delivery field, favoring hydrogel-forming capacities for cutaneous application towards several dermatological conditions. Essential oils have been widely used in skin, not only for their remarkable biological properties, but also for their capacity to enhance permeation through the skin layers and to confer a pleasant scent to the formulation. In this study, menthol, L-linalool, bergamot oil, and β-pinene were incorporated in alginate/fucoidan hydrogels to evaluate their skin permeation enhancement profile and assess their influence on the skin organization. The combinations of different essential oils with the marine-based fucoidan/alginate hydrogel matrix were characterized, resulting in formulations with pseudoplastic rheological properties favorable for a uniform application in the skin. The ex vivo Franz diffusion permeation assays revealed that calcein loaded in bergamot-alginate/fucoidan hydrogel permeated more than 15 mg out of the initial 75 mg than when in linalool-alginate/fucoidan, alginate/fucoidan or hydrogel without any incorporated oil. Skin calcein retention for menthol- and pinene-alginate/fucoidan hydrogels was 15% higher than in the other conditions. Infrared micro-spectroscopic analysis through synchrotron-based Fourier Transform Infrared Microspectroscopy evidenced a symmetric shift in CH 3 groups towards higher wavenumber, indicating lipids' fluidization and less lateral packing, characterized by a band at 1468 cm -1 , with the bergamot-alginate/fucoidan, which contributes to enhancing skin permeation. The study highlights the effect of the composition in the design of formulations for topical or transdermal delivery systems.
References: Nanotechnology. 2018 Feb 09;:. (PMID: 29424698)
Pharmaceutics. 2021 Feb 02;13(2):. (PMID: 33540524)
Phytother Res. 2009 May;23(5):707-12. (PMID: 19107862)
J Pharm Pharmacol. 2015 Apr;67(4):473-85. (PMID: 25557808)
Int J Cosmet Sci. 2006 Oct;28(5):359-70. (PMID: 18489300)
Int J Cosmet Sci. 1988 Dec;10(6):281-93. (PMID: 19456942)
Mar Drugs. 2020 Mar 18;18(3):. (PMID: 32197494)
J Lipid Res. 2009 Apr;50 Suppl:S417-22. (PMID: 18980941)
Mar Drugs. 2021 Dec 11;19(12):. (PMID: 34940701)
J Pharm Sci. 1997 Dec;86(12):1369-73. (PMID: 9423148)
J Control Release. 2009 Jun 5;136(2):88-98. (PMID: 19250955)
BMC Complement Altern Med. 2017 Aug 1;17(1):378. (PMID: 28764703)
Drug Discov Today. 2007 Dec;12(23-24):1061-7. (PMID: 18061886)
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Oct 5;185:1-10. (PMID: 28527394)
Mar Drugs. 2022 Nov 15;20(11):. (PMID: 36421993)
Int J Oncol. 2012 Jan;40(1):251-60. (PMID: 21874230)
AAPS PharmSciTech. 2020 Jul 31;21(6):211. (PMID: 32737606)
Phytother Res. 2007 Apr;21(4):308-23. (PMID: 17199238)
Biomedicines. 2020 Aug 22;8(9):. (PMID: 32842682)
Mar Drugs. 2015 May 15;13(5):2967-3028. (PMID: 25988519)
J Pharm Pharmacol. 1992 Aug;44(8):640-5. (PMID: 1359086)
Dermatoendocrinol. 2009 Mar;1(2):72-6. (PMID: 20224687)
Pharmacol Biochem Behav. 2011 Jan;97(3):436-43. (PMID: 20932858)
Biochim Biophys Acta. 2006 Jul;1758(7):923-33. (PMID: 16730643)
Phytother Res. 2012 Dec;26(12):1898-903. (PMID: 22431003)
Microorganisms. 2020 Feb 06;8(2):. (PMID: 32041100)
Wound Repair Regen. 2009 Jul-Aug;17(4):505-10. (PMID: 19527480)
Carbohydr Res. 2003 Jan 20;338(2):153-65. (PMID: 12526839)
Int J Pharm. 2000 Feb 15;195(1-2):171-7. (PMID: 10675694)
Ther Deliv. 2017 Jul;8(8):701-718. (PMID: 28730938)
Am J Clin Dermatol. 2004;5(4):217-23. (PMID: 15301569)
Mar Drugs. 2016 Jul 29;14(8):. (PMID: 27483292)
Biol Pharm Bull. 2007 Feb;30(2):343-9. (PMID: 17268077)
Food Chem. 2013 Nov 15;141(2):1211-7. (PMID: 23790906)
J Investig Allergol Clin Immunol. 2012;22(3):180-7. (PMID: 22697007)
Curr Pharm Des. 2004;10(9):967-81. (PMID: 15078127)
Sci Rep. 2017 Mar 13;7:44236. (PMID: 28287146)
Chem Phys Lipids. 2021 May;236:105055. (PMID: 33561467)
Eur J Pharm Biopharm. 2008 Aug;69(3):1040-5. (PMID: 18411045)
Materials (Basel). 2019 Oct 12;12(20):. (PMID: 31614735)
Mar Drugs. 2016 Feb 05;14(2):. (PMID: 26861358)
J Agric Food Chem. 2010 May 12;58(9):5438-43. (PMID: 20392042)
Mar Drugs. 2022 Sep 27;20(10):. (PMID: 36286430)
J Invest Dermatol. 1986 Mar;86(3):255-9. (PMID: 3745950)
Mar Drugs. 2015 May 06;13(5):2770-84. (PMID: 25955754)
Mar Drugs. 2015 Apr 14;13(4):2327-46. (PMID: 25874926)
Eur J Pharm Biopharm. 2017 Jul;116:38-50. (PMID: 27867112)
Molecules. 2017 Jan 01;22(1):. (PMID: 28045446)
Molecules. 2016 Jun 16;21(6):. (PMID: 27322222)
Biomolecules. 2019 Nov 14;9(11):. (PMID: 31739596)
Prog Polym Sci. 2012 Jan;37(1):106-126. (PMID: 22125349)
Biomaterials. 2018 Feb;156:204-216. (PMID: 29216534)
Molecules. 2008 Aug 12;13(8):1671-95. (PMID: 18794778)
Dermatitis. 2016 Jul-Aug;27(4):161-9. (PMID: 27427817)
Pharm Res. 1991 Jan;8(1):17-24. (PMID: 2014203)
Macromol Biosci. 2006 Aug 7;6(8):623-33. (PMID: 16881042)
Mar Drugs. 2019 Dec 06;17(12):. (PMID: 31817687)
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):99-109. (PMID: 25857837)
Int Immunopharmacol. 2019 Oct;75:105823. (PMID: 31422184)
Int J Pharm. 2003 Jun 4;258(1-2):217-23. (PMID: 12753768)
Int J Biol Macromol. 2019 Mar 1;124:1115-1122. (PMID: 30521895)
Pharmaceutics. 2015 Oct 22;7(4):438-70. (PMID: 26506371)
J Pharm Biomed Anal. 2019 Aug 5;172:94-102. (PMID: 31029804)
Ther Deliv. 2015;6(9):1053-61. (PMID: 26458111)
Drug Dev Ind Pharm. 2013 Nov;39(11):1750-7. (PMID: 23216218)
Pharmazie. 2010 Feb;65(2):102-5. (PMID: 20225652)
J Liposome Res. 2011 Jun;21(2):134-40. (PMID: 20557280)
Int J Pharm. 2012 Oct 1;435(1):3-9. (PMID: 22705878)
Int J Mol Sci. 2019 Jul 25;20(15):. (PMID: 31349657)
Food Chem Toxicol. 2011 Aug;49(8):1745-52. (PMID: 21570441)
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111667. (PMID: 33545832)
J Oral Maxillofac Pathol. 2018 Jan-Apr;22(1):86-91. (PMID: 29731562)
Arch Dermatol Res. 2011 Aug;303(6):425-31. (PMID: 21191796)
J Biomed Mater Res A. 2009 Aug;90(2):411-8. (PMID: 18523947)
Mar Drugs. 2020 May 22;18(5):. (PMID: 32456047)
Biochim Biophys Acta. 2008 May;1778(5):1344-55. (PMID: 18298945)
Pharmaceutics. 2018 Jun 14;10(2):. (PMID: 29899219)
Polymers (Basel). 2020 Oct 20;12(10):. (PMID: 33092194)
ACS Omega. 2020 Jul 08;5(28):17152-17159. (PMID: 32715200)
Phytomedicine. 2002 Dec;9(8):721-6. (PMID: 12587692)
Cancer Cell Int. 2020 May 7;20:154. (PMID: 32410882)
Mar Drugs. 2018 Nov 21;16(11):. (PMID: 30469402)
Expert Opin Drug Deliv. 2020 Feb;17(2):145-155. (PMID: 31910342)
Drug Dev Ind Pharm. 2002 Jul;28(6):621-30. (PMID: 12149954)
Food Chem. 2018 Dec 1;268:179-187. (PMID: 30064746)
معلومات مُعتمدة: SFRH/BD/147038/2019 Fundação para a Ciência e Tecnologia; CEECINST/00007/2021 Fundação para a Ciência e Tecnologia; UID/QUI/50006/2020 Fundação para a Ciência e Tecnologia
فهرسة مساهمة: Keywords: cutaneous delivery; marine polysaccharides; penetration enhancers; stratum corneum layer; synchrotron-based Fourier transform infrared microspectroscopy
تواريخ الأحداث: Date Created: 20230121 Latest Revision: 20230201
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC9861241
DOI: 10.3390/pharmaceutics15010190
PMID: 36678818
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4923
DOI:10.3390/pharmaceutics15010190